Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

miR-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts.

Condorelli AG, Logli E, Cianfarani F, Teson M, Diociaiuti A, El Hachem M, Zambruno G, Castiglia D, Odorisio T.

Br J Dermatol. 2019 Feb 28. doi: 10.1111/bjd.17840. [Epub ahead of print]

PMID:
30816994
2.

Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa.

Cianfarani F, De Domenico E, Nyström A, Mastroeni S, Abeni D, Baldini E, Ulisse S, Uva P, Bruckner-Tuderman L, Zambruno G, Castiglia D, Odorisio T.

Matrix Biol. 2019 Aug;81:3-16. doi: 10.1016/j.matbio.2018.12.001. Epub 2018 Dec 5.

PMID:
30528862
3.

Lack of K140 immunoreactivity in junctional epidermolysis bullosa skin and keratinocytes associates with misfolded laminin epidermal growth factor-like motif 2 of the β3 short arm.

Condorelli AG, Fortugno P, Cianfarani F, Proto V, Di Zenzo G, Didona B, Zambruno G, Castiglia D.

Br J Dermatol. 2018 Jun;178(6):1416-1422. doi: 10.1111/bjd.15690. Epub 2018 Feb 22.

PMID:
28561256
4.

Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces.

La Manna S, Scognamiglio PL, Di Natale C, Leone M, Mercurio FA, Malfitano AM, Cianfarani F, Madonna S, Caravella S, Albanesi C, Novellino E, Marasco D.

Biochimie. 2017 Jul;138:106-115. doi: 10.1016/j.biochi.2017.05.002. Epub 2017 May 4.

PMID:
28479106
5.

Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.

Cianfarani F, Zambruno G, Castiglia D, Odorisio T.

Am J Pathol. 2017 Jul;187(7):1445-1453. doi: 10.1016/j.ajpath.2017.03.003. Epub 2017 Apr 29. Review.

PMID:
28460207
6.

The E3 ligase Itch knockout mice show hyperproliferation and wound healing alteration.

Giamboi-Miraglia A, Cianfarani F, Cattani C, Lena AM, Serra V, Campione E, Terrinoni A, Zambruno G, Odorisio T, Di Daniele N, Melino G, Candi E.

FEBS J. 2015 Dec;282(23):4435-49. doi: 10.1111/febs.13514. Epub 2015 Oct 12.

7.

Interleukin-22 Promotes Wound Repair in Diabetes by Improving Keratinocyte Pro-Healing Functions.

Avitabile S, Odorisio T, Madonna S, Eyerich S, Guerra L, Eyerich K, Zambruno G, Cavani A, Cianfarani F.

J Invest Dermatol. 2015 Nov;135(11):2862-2870. doi: 10.1038/jid.2015.278. Epub 2015 Jul 13.

8.

Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.

Odorisio T, Di Salvio M, Orecchia A, Di Zenzo G, Piccinni E, Cianfarani F, Travaglione A, Uva P, Bellei B, Conti A, Zambruno G, Castiglia D.

Hum Mol Genet. 2014 Aug 1;23(15):3907-22. doi: 10.1093/hmg/ddu102. Epub 2014 Mar 5.

PMID:
24599399
9.

A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration.

Di Zenzo G, El Hachem M, Diociaiuti A, Boldrini R, Calabresi V, Cianfarani F, Fortugno P, Piccinni E, Zambruno G, Castiglia D.

Br J Dermatol. 2014 May;170(5):1056-64. doi: 10.1111/bjd.12816.

PMID:
24387836
10.

Diabetes impairs adipose tissue-derived stem cell function and efficiency in promoting wound healing.

Cianfarani F, Toietta G, Di Rocco G, Cesareo E, Zambruno G, Odorisio T.

Wound Repair Regen. 2013 Jul-Aug;21(4):545-53. doi: 10.1111/wrr.12051. Epub 2013 Apr 29.

PMID:
23627689
11.

MicroRNA-203 contributes to skin re-epithelialization.

Viticchiè G, Lena AM, Cianfarani F, Odorisio T, Annicchiarico-Petruzzelli M, Melino G, Candi E.

Cell Death Dis. 2012 Nov 29;3:e435. doi: 10.1038/cddis.2012.174.

12.

Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity.

Cianfarani F, Mastroeni S, Odorisio T, Passarelli F, Cattani C, Mannooranparampil TJ, Fortes C, Failla CM.

J Cutan Pathol. 2012 Sep;39(9):826-34. doi: 10.1111/j.1600-0560.2012.01955.x. Epub 2012 Jul 16.

PMID:
22804631
13.

Impaired keratinocyte proliferative and clonogenic potential in transgenic mice overexpressing 14-3-3σ in the epidermis.

Cianfarani F, Bernardini S, De Luca N, Dellambra E, Tatangelo L, Tiveron C, Niessen CM, Zambruno G, Castiglia D, Odorisio T.

J Invest Dermatol. 2011 Sep;131(9):1821-9. doi: 10.1038/jid.2011.137. Epub 2011 Jun 9.

14.

STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.

Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, Girolomoni G, Albanesi C.

FASEB J. 2011 Mar;25(3):916-27. doi: 10.1096/fj.10-172288. Epub 2010 Nov 23.

PMID:
21098725
15.

Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.

Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A.

J Clin Invest. 2009 Dec;119(12):3573-85. doi: 10.1172/JCI40202. Epub 2009 Nov 16.

16.

TSH receptor and thyroid-specific gene expression in human skin.

Cianfarani F, Baldini E, Cavalli A, Marchioni E, Lembo L, Teson M, Persechino S, Zambruno G, Ulisse S, Odorisio T, D'Armiento M.

J Invest Dermatol. 2010 Jan;130(1):93-101. doi: 10.1038/jid.2009.180.

17.

HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration.

Fitsialos G, Bourget I, Augier S, Ginouvès A, Rezzonico R, Odorisio T, Cianfarani F, Virolle T, Pouysségur J, Meneguzzi G, Berra E, Ponzio G, Buscà R.

J Cell Sci. 2008 Sep 15;121(Pt 18):2992-3001. doi: 10.1242/jcs.029256. Epub 2008 Aug 19.

18.

The court medical expert in France: changes in status.

Bartoli C, Giocanti D, Piercecchi-Marti D, Pelissier-Alicot AL, Cianfarani F, Leonetti G.

Med Sci Law. 2006 Oct;46(4):328-34.

PMID:
17191636
19.

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, Capogrossi MC, Failla CM, Napolitano M, Odorisio T.

Am J Pathol. 2006 Oct;169(4):1167-82.

20.

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM.

Am J Pathol. 2006 Aug;169(2):643-54.

21.

Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.

Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T.

Br J Dermatol. 2006 Jan;154(1):34-41.

PMID:
16403091
22.

SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.

Tartaglia-Polcini A, Bonnart C, Micheloni A, Cianfarani F, Andrè A, Zambruno G, Hovnanian A, D'Alessio M.

J Invest Dermatol. 2006 Feb;126(2):315-24.

23.

The placenta growth factor in skin angiogenesis.

Odorisio T, Cianfarani F, Failla CM, Zambruno G.

J Dermatol Sci. 2006 Jan;41(1):11-9. Epub 2005 Oct 10. Review. Erratum in: J Dermatol Sci. 2004 Jul;43(1):71.

PMID:
16216466
24.

The regional commission for medical accidents and nosocomial infections set up by French law.

Bartoli C, Piercecchi-Marti MD, Pelissier-Alicot AL, Cianfarani F, Leonetti G.

Med Sci Law. 2005 Jul;45(3):211-8.

PMID:
16117281
25.

Pellagra: a rare disease observed in a victim of mental and physical abuse.

Piercecchi-Marti MD, Pélissier-Alicot AL, Leonetti G, Tervé JP, Cianfarani F, Pellissier JF.

Am J Forensic Med Pathol. 2004 Dec;25(4):342-4.

PMID:
15577526
26.

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G.

Cancer. 2003 Aug 15;98(4):789-97.

27.

Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.

Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G.

J Cell Sci. 2002 Jun 15;115(Pt 12):2559-67.

28.

Immunostaining by complement C9: a tool for early diagnosis of myocardial infarction and application in forensic medicine.

Piercecchi-Marti MD, Lepidi H, Leonetti G, Vire O, Cianfarani F, Pellissier JF.

J Forensic Sci. 2001 Mar;46(2):328-34.

PMID:
11305435
29.

Modulation of cholinergic marker expression by nerve growth factor in dorsal root ganglia.

Biagioni S, Tata AM, Agrati C, Cianfarani F, Augusti-Tocco G.

J Neurosci Res. 2000 Nov 15;62(4):591-9.

PMID:
11070503
30.

Placenta growth factor is induced in human keratinocytes during wound healing.

Failla CM, Odorisio T, Cianfarani F, Schietroma C, Puddu P, Zambruno G.

J Invest Dermatol. 2000 Sep;115(3):388-95.

31.

Evaluation of biological stress markers in police officers.

Piercecchi-Marti MD, Leonetti G, Pelissier AL, Conrath J, Cianfarani F, Valli M.

Med Law. 1999;18(1):125-44.

PMID:
10436744
32.

[Medical confidentiality].

Caizergues C, Cianfarani F.

Rev Prat. 1998 Feb 15;48(4):427-32. French. No abstract available.

PMID:
9781100
33.

[Variation of sphenoidal angle of human skull in the course of aging].

Léonetti G, Signoli M, Hershkovitz I, Latimer B, Tervé JP, Jellema L, Cianfarani F, Dutour O.

C R Acad Sci III. 1997 Nov;320(11):943-7. French.

PMID:
9499941
34.

[Cannabis: toxicokinetic focus and methodology of urinary screening].

Pélissier AL, Léonetti G, Villani P, Cianfarani F, Botta A.

Therapie. 1997 May-Jun;52(3):213-8. French.

PMID:
9366105
35.

[Urinary screening of drugs of abuse among drivers involved in road accidents].

Pélissier AL, Léonetti G, Kerguelen S, Bremond J, Botta A, Cianfarani F, Garnier M.

Ann Biol Clin (Paris). 1996;54(10-11):365-71. French.

PMID:
9092305
36.

[Temporomandibular joint pain-dysfunction syndrome after whiplash injury. Medico-legal problems in common law].

Bedrune B, Jammet P, Chossegros C, Cianfarani F, Souyris F, Lachard J.

Rev Stomatol Chir Maxillofac. 1992;93(6):408-13. French.

PMID:
1475614
37.

[Teeth from monkeys to Mozart].

Puech PF, Cianfarani F, Puech S.

Inf Dent. 1990 May 31;72(22):2003, 2005-8. French. No abstract available.

PMID:
2202682
38.

Maxillary canine microwear in Dryopithecus from Spain.

Puech PF, Cianfarani F, Ribot i Trafi F.

Am J Phys Anthropol. 1989 Nov;80(3):305-12.

PMID:
2511762
39.

Craniofacial dysmorphism in Mozart's skull.

Puech B, Puech PF, Tichy G, Dhellemmes P, Cianfarani F.

J Forensic Sci. 1989 Mar;34(2):487-90.

PMID:
2651556
40.

Technical note on questioned imprint.

Cianfarani F, Puech PF, Puech B.

Acta Med Leg Soc (Liege). 1989;39(2):47-9. No abstract available.

PMID:
2535397
41.

[The role of Regional Penitentiary Medico-Psychological Centers in the French system of aid to mental patients].

Cianfarani F, Masse D, Vallat G, Cano N, Guimars C, Glezer D.

Acta Med Leg Soc (Liege). 1986;36(2):191-8. French. No abstract available.

PMID:
2979363
42.

[An original procedure for ballistic identification].

Cianfarani F, Albertini H, Puech PF.

Acta Med Leg Soc (Liege). 1986;36(1):142-57. French. No abstract available.

PMID:
2979145
43.

[The value and limits of using perikymata in legal medicine and epidemiology].

Cianfarani F, Albertini H, Puech PF.

Acta Med Leg Soc (Liege). 1985;35(1):268-77. French. No abstract available.

PMID:
2979891

Supplemental Content

Loading ...
Support Center